Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic Neuromyelitis Spectrum Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06118398
What this trial is testing

Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaEfgartigimod
Feng Jinzhou 24
Testing effectiveness (Phase 2)Looking for participantsNCT05549258
What this trial is testing

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Amgen 15
Not applicableNot Yet RecruitingNCT07333196
What this trial is testing

Tongji NADs Cohort

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderAutoimmune Encephalitis+6 more
Tongji Hospital 1,550
Large-scale testing (Phase 3)Active Not RecruitingNCT06724809
What this trial is testing

Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD

Who this might be right for
NMOSDNeuromyelitis Optica Spectrum Disorders
Alexion Pharmaceuticals, Inc. 21
Early research (Phase 1)Study completedNCT03138421
What this trial is testing

Central Pain Study for ABX-1431

Who this might be right for
Neuromyelitis Optica Spectrum DisorderTransverse MyelitisMultiple Sclerosis+1 more
Abide Therapeutics 9
Large-scale testing (Phase 3)Study completedNCT02028884
What this trial is testing

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD)
Hoffmann-La Roche 85
Early research (Phase 1)Study completedNCT05432713
What this trial is testing

LP-168 in Healthy Volunteers

Who this might be right for
Multiple SclerosisNMO Spectrum Disorder
Guangzhou Lupeng Pharmaceutical Company LTD. 70
Not applicableEnrolling By InvitationNCT06643858
What this trial is testing

Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)

Who this might be right for
HealthyMultiple SclerosisNeuromyelitis Optica Spectrum Disorders+2 more
Beijing Tiantan Hospital 10,000
Not applicableUnknownNCT06443333
What this trial is testing

National, Multicentric Registry Study on Neuroimmunological Diseases in China

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+3 more
Xuanwu Hospital, Beijing 7,000
Not applicableUnknownNCT03514030
What this trial is testing

Clinic Registry Study of Optic Neuromyelitis Spectrum Disease in China

Who this might be right for
NMO Spectrum Disorder;Registry Study
Beijing Tongren Hospital 400
Not applicableUnknownNCT05605951
What this trial is testing

Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve

Who this might be right for
Demyelinating DiseasesMultiple SclerosisNeuromyelitis Optica Spectrum Disorder Attack+2 more
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul 200
Not applicableUnknownNCT05891379
What this trial is testing

Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Xuanwu Hospital, Beijing 50
Not applicableUnknownNCT02836327
What this trial is testing

Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum Disorders
Chinese PLA General Hospital 300
Very early researchLooking for participantsNCT05145361
What this trial is testing

Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)

Who this might be right for
NMO Spectrum Disorder
Shanghai Pharmaceuticals Holding Co., Ltd 45
Not applicableNot Yet RecruitingNCT07159893
What this trial is testing

Inectolizumab With Steroid Optimization in Newly Treated NMOSD

Who this might be right for
Neuromyelitis OpticaAutoimmune DiseasesDemyelinating Autoimmune Diseases, CNS
First Affiliated Hospital of Wenzhou Medical University 25
Testing effectiveness (Phase 2)WithdrawnNCT05974293
What this trial is testing

A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders

Who this might be right for
NMO Spectrum DisorderSpasticity, Muscle
Michael, Levy M.D.,Ph.D.
Not applicableLooking for participantsNCT05566769
What this trial is testing

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

Who this might be right for
Neuromyelitis Optica
Ad scientiam 103
Early research (Phase 1)Study completedNCT04227470
What this trial is testing

HBM9161 in NMOSD Patients

Who this might be right for
NMO Spectrum Disorder
Harbour BioMed (Guangzhou) Co. Ltd. 9
Large-scale testing (Phase 3)Study completedNCT02200770
What this trial is testing

N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
MedImmune LLC 231
Not applicableStudy completedNCT02850705
What this trial is testing

The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)

Who this might be right for
Neuromyelitis Optica Spectrum DisordersNeuromyelitis Optica Spectrum Related Disorders
Hospices Civils de Lyon 1,787
Next Page